These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3901618)
1. The therapeutic response of cephalosporin-treated E. coli pyelonephritis of the rat, in relation to variations of the infection model. Schulz E; Marre R; Herhahn D; Sack K Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):531-7. PubMed ID: 3901618 [TBL] [Abstract][Full Text] [Related]
2. Standardization of a model of E. coli-pyelonephritis in rats. Schulz E; Marre R; Sack K; Herhahn D Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):490-6. PubMed ID: 6377761 [TBL] [Abstract][Full Text] [Related]
3. [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats]. Tietgen K; Schulz E; Boness J; Marre R Immun Infekt; 1986 Jul; 14(4):152-5. PubMed ID: 2943665 [TBL] [Abstract][Full Text] [Related]
4. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Yagmurlu A; Boleken ME; Ertoy D; Ozsan M; Gokcora IH; Dindar H Urology; 2003 May; 61(5):1037-41. PubMed ID: 12736043 [TBL] [Abstract][Full Text] [Related]
5. Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats. Marre R; Herhahn D; Schulz E; Freiesleben H; Sack K Infection; 1983; 11 Suppl 1():S54-6. PubMed ID: 6299968 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department. Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271 [TBL] [Abstract][Full Text] [Related]
7. Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis. Meylan PR; Braoudakis G; Glauser MP Antimicrob Agents Chemother; 1986 May; 29(5):760-4. PubMed ID: 3524429 [TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental ascending Escherichia coli pyelonephritis with ceftriaxone alone and in combination with gentamicin. Glauser MP; Bonard Chemotherapy; 1982; 28(5):410-6. PubMed ID: 6291870 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of 5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone (LM49) in an experimental rat model of acute pyelonephritis by immunomodulation and anti-inflammation. Zhang YL; Feng XE; Chang RR; Zhang LH; Xiao BG; Li QS; Hao XL Int Immunopharmacol; 2018 Sep; 62():155-164. PubMed ID: 30007245 [TBL] [Abstract][Full Text] [Related]
10. Bacterial interference as a factor in renal infection. Miller TE; Creaghe E J Lab Clin Med; 1976 May; 87(5):792-803. PubMed ID: 5564 [TBL] [Abstract][Full Text] [Related]
11. [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)]. Hagemann I; Briedigkeit H; Strangfeld D; Precht K; Ditscherlein G; Puls U; Neubrandt C; Pietsch R; Kruse I Z Urol Nephrol; 1985 Dec; 78(12):681-8. PubMed ID: 3913223 [TBL] [Abstract][Full Text] [Related]
12. L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis. Tardif M; Beauchamp D; Bergeron Y; Lessard C; Gourde P; Bergeron MG Antimicrob Agents Chemother; 1994 Jul; 38(7):1555-60. PubMed ID: 7979288 [TBL] [Abstract][Full Text] [Related]
13. In vivo significance of the inoculum effect of antibiotics on Escherichia coli. Soriano F; Santamaría M; Ponte C; Castilla C; Fernández-Roblas R Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):410-2. PubMed ID: 3137046 [TBL] [Abstract][Full Text] [Related]
14. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice. Gupta R; Ganguly NK; Ahuja V; Joshi K; Sharma S J Med Microbiol; 1995 Jul; 43(1):33-6. PubMed ID: 7608952 [TBL] [Abstract][Full Text] [Related]
15. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis. Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin. Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246 [TBL] [Abstract][Full Text] [Related]
17. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model. Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats. Kim KS; Manocchio M; Bayer AS Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gentamicin in the treatment of renal infection: a therapeutic anomaly explained. Miller T; Phillips S; North D Kidney Int; 1979 Feb; 15(2):160-6. PubMed ID: 390210 [No Abstract] [Full Text] [Related]
20. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats]. Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]